Latest filing published 14 Sept 2026 for Korro Bio, Inc., €380k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Atlas Venture Fund XI, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Korro Bio, Inc. and Dyne Therapeutics, Inc. The record holds 19 filings, for trades running from 22 June 2026 to 14 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 14 September 2026, the filings show a transaction worth €380k in Korro Bio, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations